Ben-Gurion University of the Negev professor awarded the 2010 Elkeles Prize for Cancer Research

10-Aug-2010 - Israel

Ben-Gurion University of the Negev (BGU) Professor Ron N. Apte has been awarded the 2010 Samuel and Paula Elkeles Prize for Outstanding Scientist in the Field of medicine. Professor Apte is chairman of the Shraga Segal Department of microbiology and immunology and vice dean of the Basic Sciences division in the BGU Faculty of Health Sciences. He is also the Irving Sklar Chair in endocrinology and Cancer and a member of the National Institute for biotechnology in the Negev.

Apte's major field of research involves inflammation in malignant processes. Approximately 15 percent of cancers are connected to inflammation, which typically result in organs where chronic inflammation has occurred. For example, patients with Inflammatory Bowel Disease (IBD) are more prone to cancer than the general population.

The pioneering studies of Apte's group demonstrated the feasibility of intervening in malignant process by neutralizing inflammatory components in the "normal" microenvironment of a tumor. They also detailed the basic concepts underlying such treatment.

Inflammatory cells affect proliferation and invasiveness of malignant cells through the secretion of cytokines, which include Interleukin-1 (IL-1), the molecule that has been studied for years by Apte's group. The group has demonstrated the involvement of IL-1-mediated inflammation in tumor invasiveness and metastasis. IL-1 causes tumor expansion because it suppresses the immune system and nourishes a tumor's blood vessels. Apte's group treated tumor-bearing mice with a specific inhibitor of IL-1, known as the IL-1 receptor antagonist (IL-Ra), and succeeded in weakening the tumor's invasiveness.

IL-Ra, in its generic form Anakirna, is a medication that efficiently alleviates symptoms of patients suffering from rheumatoid arthritis, a chronic inflammatory disease.

Other news from the department people

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

Last viewed contents

X-ray laser uncovers the structure of a natural anti-mosquito insecticide - Bacterial protein found to work against more species of mosquito as previously thought

X-ray laser uncovers the structure of a natural anti-mosquito insecticide - Bacterial protein found to work against more species of mosquito as previously thought

Shifting meetings, conventions online curbs climate change - The annual carbon footprint for the global event and convention industry is on par with the yearly greenhouse gas emissions of the entire U.S.

Shifting meetings, conventions online curbs climate change - The annual carbon footprint for the global event and convention industry is on par with the yearly greenhouse gas emissions of the entire U.S.

New pathways found for biotechnological degradation of industrial waste - Microorganism breaks down phenol under extreme conditions

New pathways found for biotechnological degradation of industrial waste - Microorganism breaks down phenol under extreme conditions

Applied Biosystems, Roche Molecular Systems, Bio-Rad, and MJ Research Reach Settlement Agreement Regarding Thermal Cyclers

How drugs get into the blood - This knowledge facilitates the development of drugs that can also be taken in tablet form

How drugs get into the blood - This knowledge facilitates the development of drugs that can also be taken in tablet form

Impact of prion proteins on the nerves revealed for the first time - 30-year-old research question finally answered

Johns Hopkins researchers say vaccine appears to 'mop up' leukemia cells Gleevec leaves behind

Study pinpoints, prevents stress-induced drug relapse in rats

Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection

Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection

List_of_medical_abbreviations

New biotech venture PHIOGEN to tackle the global threat of antimicrobial resistance - By optimizing nature’s defenders, the team has produced unprecedented phage treatments

New biotech venture PHIOGEN to tackle the global threat of antimicrobial resistance - By optimizing nature’s defenders, the team has produced unprecedented phage treatments

Epigenomics AG Successfully Validates Lung Cancer Test in Clinical Trial